Pfizer has agreed to acquire Array Biopharma for approximately $11.4 billion in cash, including debt.
Shares of Array Biopharma soared 59% in premarket trading on the news.
The boards of directors of both companies have approved the merger.
This is breaking news. Please check back for updates.